Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06794021 · ClinicalTrials.gov registry record · NA
One Week Clinical Study in Subjects With Menopausal Symptoms
A NA study, sponsored by Olly, PBC.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT06794021: Completed NA study, sponsored by Olly, PBC.
NCT06794021 is a NA study that has completed, run by Olly, PBC. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06794021, a NA study, has completed, sponsored by Olly, PBC.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to Examine the Benefits of an Oral Product in Subjects With Menopausal Symptoms. The main questions it aims to answer are: 1. To assess the efficacy for improvement of menopausal vasomotor symptoms within 24 hours compared to placebo through Daily Diary and Mobile Application 2. To assess the efficacy for improvement of menopausal vasomotor symptoms hours compared to placebo through days 2-6 Daily Diary and Mobile Application 3. To assess the efficacy of the investigation product on stress/anxiety, mood swings, headaches compared to placebo through days 1-6 and with use of Daily Diary, Mobile Application and validated questionnaires (GCS, MENQOL). 4. To assess the efficacy of the investigation product on mood, stress and sleep at 7 days post treatment using validated questionnaires (PSQI, PSS, POMS)
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Dietary Supplement with Proprietary Herbal Extract Blend and GABA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-01-21 |
| Est. Completion | 2025-04-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06794021
The ClinicalTrials.gov registry entry for NCT06794021 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Olly, PBC, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT06794021 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06794021 about?
NCT06794021 is a clinical study titled "One Week Clinical Study in Subjects With Menopausal Symptoms". The goal of this clinical trial is to Examine the Benefits of an Oral Product in Subjects With Menopausal Symptoms. The main questions it aims to answer are: 1. To assess the efficacy for improvement of menopausal vasomotor symptoms within 24 hours compared to placebo through Daily Diary and Mobile...
What is the current status of trial NCT06794021?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2025-01-21. Estimated completion is 2025-04-22.
What interventions are being tested in trial NCT06794021?
The interventions under investigation include: Placebo (OTHER), Dietary Supplement with Proprietary Herbal Extract Blend and GABA (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06794021?
This trial is sponsored by Olly, PBC, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.